TGFB1 and hypoparathyroidism-retardation-dysmorphism syndrome: In line with these findings, the present study demonstrated that Sal B treatment significantly lowered the elevated levels of IL-6, NGAL, and TGF-β in the HRD model, highlighting its anti-inflammatory, renoprotective, and anti-fibrotic properties.